Part D results
CMS's year-end Part D reconciliation, 2022–2024. When a plan's actual drug costs land well above its bid, CMS shares the loss through risk sharing (the "risk corridors"); when they land well below, the plan pays CMS back. A large positive amount means the plan's drug bid was badly underpriced. 2024 is the latest year CMS has published.
How to read this
Risk sharing: positive = CMS paid the plan (costs ran over the bid by more than the corridor); negative = the plan paid CMS. These are CMS's settled figures. Plans also report risk sharing in their MLR filings, sometimes as an estimate made before CMS settled, so a filing can differ.
Per member per year: risk sharing ÷ Part D member-months × 12. Part D member-months include stand-alone drug plan (PDP) members.
CMS's reconciliation also settles reinsurance (catastrophic drug costs) and low-income cost sharing; those are pass-through subsidies, not a sign of profit or loss, so they're shown on contract pages only.
| 2024 | 2023 | 2022 | 3-year total | Per member per year2024 | Part D members2024 avg | |
|---|---|---|---|---|---|---|
| H9572 Blue Cross Blue Shield of Michigan | $7.9M | $10.4M | $3.6M | $21.9M | $14 | 560,151 |
| S5584 Blue Cross Blue Shield of Michigan PDP | $2.2M | $3.5M | $703K | $6.4M | $79 | 28,029 |
| H5883 Blue Care Network | −$60.5K | $4.0M | $853K | $4.8M | −$1 | 100,745 |
| H6898 Vermont Blue Advantage | $1.9M | $577K | −$5.1K | $2.5M | $136 | 14,120 |
| H5900 Wellmark Advantage Health Plan | $3.0M | −$1.6M | $24.3K | $1.5M | $168 | 17,938 |
| H6202 NextBlue of North Dakota | $1.6M | −$251K | −$181K | $1.1M | $115 | 13,448 |
| H9489 Vermont Blue Advantage | $189K | $71.1K | −$46.2K | $214K | $335 | 564 |
| H8095 Wellmark Advantage Health Plan | $185K | −$82.0K | $0 | $103K | $235 | 785 |
Red = CMS paid the plan. Sorted by the 3-year total. Parent totals add up each contract under its current parent; CMS also publishes its own parent rollup, which can differ where contracts changed hands.